HCA Healthcare, Inc. (NYSE:HCA) SVP Sells $3,075,250.47 in Stock

HCA Healthcare, Inc. (NYSE:HCA) SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $320.82 on Thursday. The stock’s 50-day moving average is $313.30 and its 200-day moving average is $351.29. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The firm has a market cap of $81.26 billion, a price-to-earnings ratio of 14.60, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the firm earned $5.90 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.90%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.02%.

Institutional Investors Weigh In On HCA Healthcare

Large investors have recently made changes to their positions in the stock. Creative Planning lifted its stake in HCA Healthcare by 37.6% in the third quarter. Creative Planning now owns 47,589 shares of the company’s stock valued at $19,342,000 after acquiring an additional 13,015 shares during the last quarter. Raymond James & Associates grew its holdings in HCA Healthcare by 5.2% during the third quarter. Raymond James & Associates now owns 120,759 shares of the company’s stock worth $49,080,000 after purchasing an additional 5,981 shares during the period. Resonant Capital Advisors LLC bought a new stake in HCA Healthcare in the third quarter valued at approximately $200,000. OLD National Bancorp IN acquired a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $315,000. Finally, Barden Capital Management Inc. lifted its holdings in HCA Healthcare by 2.9% during the 3rd quarter. Barden Capital Management Inc. now owns 2,862 shares of the company’s stock valued at $1,163,000 after purchasing an additional 82 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. KeyCorp lowered their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Barclays reduced their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Finally, Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.